Ernexa Therapeutics Inc Share Price Today: Live Updates & Key Insights

Ernexa Therapeutics Inc share price today is $0.2602, up -1.59%. The stock opened at $0.275 against the previous close of $0.27, with an intraday high of $0.2838 and low of $0.2589.

Ernexa Therapeutics Inc Share Price Chart

Ernexa Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Ernexa Therapeutics Inc Share Price Performance

$0.2602 -0.0159(-1.59%) ERNA at 23 Mar 2026 12:54 PM Biotechnology
Lowest Today 0.2589
Highest Today 0.2838
Today’s Open 0.275
Prev. Close 0.27
52 Week High 4.05
52 Week Low 0.26
Day’s Range: Low 0.2589 High 0.2838
52-Week Range: Low 0.26 High 4.05
1 day return -
1 Week return -12.98
1 month return -5.98
3 month return -79.58
6 month return -78.57
1 year return -0.8
3 year return -91.97
5 year return -99.8
10 year return -

Ernexa Therapeutics Inc Institutional Holdings

CI Private Wealth LLC 1.62

Vanguard Group Inc 0.13

Geode Capital Management, LLC 0.09

Fidelity Extended Market Index 0.06

Cinvest Azero Global FI 0.05

HRT FINANCIAL LLC 0.05

Vanguard Institutional Extnd Mkt Idx Tr 0.04

Sippican Capital Adivsors 0.04

Fidelity Series Total Market Index 0.01

Spartan Total Market Index Pool G 0.01

BlackRock Inc 0.00

Fortitude Family Office LLC 0.00

Fidelity Total Market Index 0.00

Genworth Financial Wealth Mgmt Inc 0.00

Morgan Stanley - Brokerage Accounts 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Bank of America Corp 0.00

BNYM Mellon SL Market Completion UC1 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

SSgA U.S. Total Market Index Strategy 0.00

Activest Wealth Management 0.00

A. Montag & Associates Inc 0.00

BNP Paribas Arbitrage, SA 0.00

BNYM Mellon NSL Mkt Completion Fund Inst 0.00

EverSource Wealth Advisors, LLC 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Susquehanna International Group, LLP 0.00

Tower Research Capital LLC 0.00

UBS Group AG 0.00

Ernexa Therapeutics Inc Market Status

Ernexa Therapeutics Inc Fundamentals

Market Cap 7.20 M

PB Ratio 1.9826

PE Ratio 0.005

Enterprise Value 4.58 M

Total Assets 5.83 M

Volume 1834523

Ernexa Therapeutics Inc Company Financials

Annual Revenue FY23:51000 0.1M, FY22:0 0.0M, FY21:0 0.0M, FY20:5800000 5.8M, FY19:19806000 19.8M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:-5765000 -5.8M, FY20:5599000 5.6M, FY19:19446000 19.4M

Annual Net worth FY23:-20004000 -20.0M, FY22:-24579000 -24.6M, FY21:-122306000 -122.3M, FY20:11906000 11.9M, FY19:-2047000 -2.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:487000 0.5M, Q2/2024:47000 0.0M

Quarterly Profit Q3/2025:0 0.0M, Q2/2025:-55000 -0.1M, Q1/2025:-69000 -0.1M, Q3/2024:547000 0.5M, Q2/2024:-48000 -0.0M

Quarterly Net worth Q3/2025:-1240000 -1.2M, Q2/2025:-3139000 -3.1M, Q1/2025:-8202000 -8.2M, Q3/2024:-26604000 -26.6M, Q2/2024:-5529000 -5.5M

About Ernexa Therapeutics Inc & investment objective

Company Information Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Ernexa Therapeutics Inc FAQs

What is the share price of Ernexa Therapeutics Inc today?

The current share price of Ernexa Therapeutics Inc is $0.2602.

Can I buy Ernexa Therapeutics Inc shares in India?

Yes, Indian investors can buy Ernexa Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Ernexa Therapeutics Inc shares in India?

You can easily invest in Ernexa Therapeutics Inc shares from India by:

Can I buy fractional shares of Ernexa Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Ernexa Therapeutics Inc?

Ernexa Therapeutics Inc has a market cap of $7.20 M.

In which sector does Ernexa Therapeutics Inc belong?

Ernexa Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Ernexa Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Ernexa Therapeutics Inc?

The PE ratio of Ernexa Therapeutics Inc is 0.01 and the PB ratio is 1.98.